±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1416  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

[ÇóÖú] »ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò

»ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò
»Ø¸´´ËÂ¥
Çó¹¤×÷
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, ÈÈÐĽ±Àø 2012-09-20 08:33:12
¼û¸½¼þͼƬÊý¾Ý

crizotinib.JPG

5Â¥2012-09-18 16:49:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 9 ¸ö»Ø´ð

songxiangen

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:53
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein.[1] A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as NPM-ALK has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL). [2]
After incubation with Crizotinib (PF-02341066), cells were washed once with HBSS supplemented with 1 mmol/L Na3VO4 and protein lysates were generated. Subsequently, phosphorylation of ALK was assessed by a sandwich ELISA method using an immobilized anti¨Ctotal-ALK antibody and an anti¨Cphospho-ALK antibody (pY1604) as a detec ion antibody.
Crizotinib (PF-02341066) inhibited NPM-ALKphosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value=24 nM).
Crizotinib (PF-02341066) potently inhibited cell proliferation, which was associated with G1-S¨Cphase cell cycle arrest and induction of apoptosis in ALK-positive ALCL cells (IC50 values=30 nM) but not ALK-negative lymphoma cells. The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase¨Cmediated nick-end labeling and Annexin V staining (IC50 values=25¨C50 nM). [3]

Crizotinib (PF-02341066) ²Î¿¼ÎÄÏ×
[1] Blood 2005;105: 2640-2653
[2] Oncogene 2001;20:5623-5637
[3] Mol Cancer Ther 2007;6:3314-3322

²»ÖªµÀ¶ÔÂ¥Ö÷ÓÐûÓÐÓÃ
2Â¥2012-09-18 11:35:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

ÒýÓûØÌû:
2Â¥: Originally posted by songxiangen at 2012-09-18 11:35:33
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein. A t(2;5) chromosomal translocation r ...

ϸ°û»îÐÔ£¬ÎÒÒªµÄÊÇø»îÐÔ£¬Óб¨µÀ˵СÓÚ1nM,µ«²»ÖªµÀ¾ßÌåÊý¾Ý
Çó¹¤×÷
3Â¥2012-09-18 15:02:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
angelhunte: ½ð±Ò+8, ¡ïÓаïÖú, ÖÁÉÙ˵Ã÷ÄúÈÏÕæ¿´¹ý 2012-09-18 22:37:21
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:59
»¹ÊÇÎÒÀ´Ó¦´ð°É£¡
crizotinibµÄALKøÒÖÖÆÂÊ99%£¨1΢Ħ¶ûŨ¶ÈÏ£©£¬ALKøÒÖÖÆIC50СÓÚ1nm¡£
²Î¿¼ÎÄÏ×£ºJournal of Medicinal chemistry 2011£¬ 54£¬ 6342-6363£¨Table¡£5.£©
4Â¥2012-09-18 16:41:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +4 kikiki7 2026-03-30 4/200 2026-03-30 06:46 by zhyzzh
[¿¼ÑÐ] 085600£¬²ÄÁÏÓ뻯¹¤321·ÖÇóµ÷¼Á +10 ´ó²öС×Ó 2026-03-28 10/500 2026-03-29 23:35 by ·ÉÐÐÈÕ¼ÇÎ÷
[¿¼ÑÐ] ¸÷λÀÏʦºÃ£¬ÎÒµÄһ־ԸΪ±±¾©¿Æ¼¼´óѧ085601²ÄÁÏר˶ +9 Koxui 2026-03-28 9/450 2026-03-29 20:43 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Çóµ÷¼Á +4 Çà´º²ÃΪÈý½Ø 2026-03-29 4/200 2026-03-29 15:01 by ÌÆãå¶ù
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +9 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 10/500 2026-03-28 22:17 by chemzp
[¿¼ÑÐ] 311£¨085601£©Çóµ÷¼Á +4 liziyeyeye 2026-03-28 4/200 2026-03-28 18:50 by 535743368
[¿¼ÑÐ] 283Çóµ÷¼Á +3 A child 2026-03-28 3/150 2026-03-28 15:41 by ms629
[¿¼ÑÐ] 286Çóµ÷¼Á +12 PolarBear11 2026-03-26 12/600 2026-03-28 12:14 by zllcz
[¿¼ÑÐ] 086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á +6 °¢Ò̸´¹Å²»¹ý 2026-03-27 6/300 2026-03-28 07:06 by wangy0907
[¿¼ÑÐ] 266·ÖÇó²ÄÁÏ»¯¹¤Ò±½ð¿óÒµµÈרҵµÄµ÷¼Á +4 ÍÛºôºßºôºß 2026-03-26 4/200 2026-03-27 17:02 by zhyzzh
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸ÄÏÅ©083200ʳƷ¿ÆÑ§Ó빤³Ì +5 XQTJZ 2026-03-26 5/250 2026-03-27 14:49 by ¿ñìÅÂóµ±µ±
[¿¼ÑÐ] Çóµ÷¼Á323²ÄÁÏÓ뻯¹¤ +7 1124361 2026-03-24 7/350 2026-03-27 10:22 by wangjy2002
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-26 6/300 2026-03-26 18:03 by Çñgl
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢Çóµ÷¼Á 324 +4 Promise-jyl 2026-03-23 4/200 2026-03-25 11:36 by Sugarlight
[¿¼ÑÐ] Çóµ÷¼Á +6 ÑÐÑУ¬½Óµç»° 2026-03-24 7/350 2026-03-24 17:01 by barlinike
[¿¼ÑÐ] 080500Çóµ÷¼Á +3 zzzzfan 2026-03-24 3/150 2026-03-24 16:38 by barlinike
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ª´ó»¯Ñ§322Çóµ÷¼Á +4 17501029541 2026-03-23 6/300 2026-03-24 10:21 by ´÷Χ²±µÄСÎÃ×Ó
[ÂÛÎÄͶ¸å] ¼±·¢ºËÐÄÆÚ¿¯ÂÛÎÄ +3 ÏÍ´ïÎʽò 2026-03-23 5/250 2026-03-23 17:13 by ÃÃ×Ó²»ºÃÈÇ
[¿¼ÑÐ] ½ÓÊÕ2026˶ʿµ÷¼Á(ѧ˶+ר˶) +4 allen-yin 2026-03-23 6/300 2026-03-23 15:04 by Íô£¡£¿£¡
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û